High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol.
about
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancerPaclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell TransplantationLong-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cellsHigh-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyRelationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer.Improvement of survival and prospect of cure in patients with metastatic breast cancer.Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.Treating breast cancer with cell-based approaches: an overview.Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargumentPilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006A Composite Synergistic Systems Model for Exploring the Efficacies of Different Chemotherapeutic Strategies in Cancer
P2860
Q24246595-B5939C42-CC4D-4C15-8768-C922DD199738Q33411110-A37019F1-BF95-40DF-9074-548125BE34DAQ33702336-D3C9FC3F-3E62-4269-ADCC-EDD079A9B822Q33959862-6EEA80D6-FAF8-4417-984F-8973C3F8EEAFQ34201582-DC25D012-81D5-4ED3-8BEC-543E1043E62AQ34366379-925431B7-87A9-4822-A1FD-18C8D8EA5B3CQ34886445-07955F8B-644E-47DC-B713-ECB8106DC48CQ35684496-C163F1D4-BD7B-4757-995A-27534BAB6BDCQ36528656-7E6533E7-2268-4A2E-B398-618548E72CE1Q36613992-1AF8B8B9-6BE4-4C9A-8AB6-9861EB81B468Q36977501-71D4DD6A-523D-4A4A-AE4A-006AF3300C4BQ37386277-054CAFBA-25DA-4B42-8099-145CD53E47CCQ38040419-A94F03D9-74BE-4D0F-A1C5-D7DA49065C4CQ39448180-FB9C16A9-3049-4205-9C74-3A5646CFBB68Q45797564-C9009D3C-2291-4F83-9ED1-F60E9B4AC9FDQ45870042-E792822A-6C6C-4CFD-BFC8-775BFBC156E6Q50912716-280345C4-0791-4AA8-BA7E-C9C2D3C9228BQ57139697-4ACADCD4-F6AA-4145-B8BA-B1E7FF703A47Q57570936-780BEFE8-9A37-406B-A7E4-F22422B16AC6Q58919527-4AF9D445-2103-445A-AAB0-F1631F2E689F
P2860
High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
High-dose chemotherapy with ha ...... omised CMA/PEGASE 04 protocol.
@en
High-dose chemotherapy with ha ...... omised CMA/PEGASE 04 protocol.
@nl
type
label
High-dose chemotherapy with ha ...... omised CMA/PEGASE 04 protocol.
@en
High-dose chemotherapy with ha ...... omised CMA/PEGASE 04 protocol.
@nl
prefLabel
High-dose chemotherapy with ha ...... omised CMA/PEGASE 04 protocol.
@en
High-dose chemotherapy with ha ...... omised CMA/PEGASE 04 protocol.
@nl
P2093
P1476
High-dose chemotherapy with ha ...... omised CMA/PEGASE 04 protocol.
@en
P2093
Abderrahmane Laadem
Bernard Asselain
Bruno Audhuy
Christian Cailliot
Christian Gisselbrecht
Christine Le Maignan
Dominique Maraninchi
François Morvan
Henri Roché
Hervé Curé
P356
10.1016/J.EJCA.2004.09.006
P577
2005-01-01T00:00:00Z